Portrait of a manipulated stock: Here is a chart t
Post# of 72440
http://bigcharts.marketwatch.com/quickchart/q...mp;time=11
So -- are we in worse or better shape than 2012? Let me count the ways....
We bought PolyMedix assets for 5 million bucks
http://cellceutix.com/cellceutix-acquires-pol...EhkOn.dpbs
4 clinical trials in progress, for 4 different applications, including 2 from the PolyMedix acquisition (Brilacidin and Bril-OM)
Article submitted on Kevetrin.
I won't bother listing the other positives.
It is plain to see that the company is grossly undervalued, and would not be so undervalued if not for the actions of a short cabal.